2'-Deoxy-5'-O-DMT-uridine

CAS: 23669-79-6

Ref. 3D-ND05965

Informação sobre produto

• Nome: 2'-Deoxy-5'-O-DMT-uridine
• Sinónimos: 5'-O-DMT-dU5'-O-(4,4'-Dimethoxytrityl)-2'-deoxyuridine2'-Deoxy-5'-O-DMT-D-uridine5'-O-DMT-2'-deoxyuridine, 1-{5-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2-deoxypentofuranosyl}pyrimidine-2,4(1H,3H)-dione, 5'-O-(4,4'-Dimethoxytrityl)-2'-Deoxyuridine, 5'-O-[Bis(4-Methoxyphenyl)Benzyl]-2'-Deoxyuridine, 5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-deoxyuridine, 5′-O-(Dimethoxytrityl)-2′-deoxyuridine, 5′-O-[Bis(4-methoxyphenyl)phenylmethyl]-2′-deoxyuridine, Uridine, 5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-deoxy-, Uridine, 5′-O-[α,α-bis(p-methoxyphenyl)benzyl]-2′-deoxy-
• CAS: 23669-79-6

Descrição

2'-Deoxy-5'-O-DMT-uridine is a bifunctional drug that has both antibacterial and anticancer activity. This drug is used to treat leishmania infections, which are caused by protozoan parasites. 2'-Deoxy-5'-O-DMT-uridine suppresses the growth of these organisms by inhibiting RNA synthesis and protein synthesis. It also inhibits proliferation of cancer cells in vivo by targeting cancer cells with high levels of primary amines. 2'-Deoxy-5'-O-DMT-uridine is an effective chemotherapeutic agent that can be used to treat pancreatic cancers with high rates of primary amines (e.g., insulinoma).

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 530.58 g/mol
• Fórmula: C₃₀H₃₀N₂O₇
• Pureza: Min. 95%
• Cor/forma: Powder